- Home
- HAE vs SEZL Comparison
HAE vs SEZL Comparison
Compare HAE & SEZL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAE
- SEZL
- Stock Information
- Founded
- HAE 1971
- SEZL 2016
- Country
- HAE United States
- SEZL United States
- Employees
- HAE N/A
- SEZL N/A
- Industry
- HAE Medical/Dental Instruments
- SEZL Diversified Financial Services
- Sector
- HAE Health Care
- SEZL Finance
- Exchange
- HAE Nasdaq
- SEZL Nasdaq
- Market Cap
- HAE 3.3B
- SEZL 3.3B
- IPO Year
- HAE 1991
- SEZL N/A
- Fundamental
- Price
- HAE $68.56
- SEZL $109.31
- Analyst Decision
- HAE Strong Buy
- SEZL Strong Buy
- Analyst Count
- HAE 9
- SEZL 2
- Target Price
- HAE $99.78
- SEZL $61.42
- AVG Volume (30 Days)
- HAE 578.9K
- SEZL 1.4M
- Earning Date
- HAE 05-08-2025
- SEZL 05-07-2025
- Dividend Yield
- HAE N/A
- SEZL N/A
- EPS Growth
- HAE 44.54
- SEZL 677.39
- EPS
- HAE 3.31
- SEZL 2.97
- Revenue
- HAE $1,360,824,000.00
- SEZL $329,060,890.00
- Revenue This Year
- HAE N/A
- SEZL $33.01
- Revenue Next Year
- HAE $6.76
- SEZL $49.84
- P/E Ratio
- HAE $20.46
- SEZL $35.95
- Revenue Growth
- HAE 3.96
- SEZL 91.69
- 52 Week Low
- HAE $55.30
- SEZL $11.50
- 52 Week High
- HAE $94.99
- SEZL $115.84
- Technical
- Relative Strength Index (RSI)
- HAE 54.87
- SEZL 80.22
- Support Level
- HAE $66.42
- SEZL $102.63
- Resistance Level
- HAE $68.75
- SEZL $115.84
- Average True Range (ATR)
- HAE 1.30
- SEZL 6.23
- MACD
- HAE -0.26
- SEZL 0.09
- Stochastic Oscillator
- HAE 45.00
- SEZL 71.72
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
About SEZL Sezzle Inc.
Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, primarily deriving revenue from payment processing platform in North America.